Benzinga | Aug 24, 2021 07:27AM EDT

Cowen & Co. Initiates Coverage On Immuneering with Outperform Rating

Cowen & Co. analyst Yaron Werber initiates coverage on Immuneering (NASDAQ:IMRX) with a Outperform rating.